Anders F.
- Country
- Sweden
- Department
- Uppsala University Children´s hospital
Research Overview
- Efficacy and Safety of Cagrilintide Monotherapy and Cagrilintide plus Semaglutide for Weight Management in Children and Adolescents with Overweight or Obesity
- Evaluation of Metformin Hydrochloride Extended Release and Immediate Release in Pediatric Obesity: A Randomized, Multicenter, Parallel-Group Study
- Long-Term Evaluation of Semaglutide for BMI Maintenance in Adolescents with Obesity Following Initial Weight Reduction
Data & Insights
Has run more than one trial at 18 of 71 partner sites.
Specializations
Pediatric Weight Management
This investigator specializes in treating childhood and adolescent obesity, conducting innovative research into pharmaceutical interventions for young patients struggling with excess weight.
- Early-onset obesity treatment
- Adolescent weight management
- Pediatric metabolic health
Their work encompasses comprehensive approaches combining medication with lifestyle modifications for children aged 6-12 years and teenagers.
Therapeutic Interventions
The investigator focuses on evaluating novel pharmaceutical treatments for pediatric weight management, including both established and emerging medications.
- Extended-release formulations
- Weekly administration protocols
- Long-term treatment strategies
Their research examines the effectiveness of different medication delivery systems in young populations.
Weight Maintenance Strategies
The investigator studies long-term weight management solutions for adolescents, with particular attention to maintaining weight loss after successful intervention.
- Post-treatment maintenance
- BMI threshold management
- Dose-tapering protocols
Their research includes extended follow-up periods to evaluate sustained weight management outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.